Efficacy of rocuronium and sugammadex in a patient with dermatomyositis

British Journal of Anaesthesia

Volumn 108, Issue 4, 2012, Pages 703-

  Suzuki, T ^a   Nameki, K ^a   Shimizu, H ^a   Shimizu, Y ^a   Nakamura, R ^a   Ogawa, S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; SUGAMMADEX;

AGED; CASE REPORT; DERMATOMYOSITIS; DRUG ANTAGONISM; DRUG EFFICACY; ELBOW FRACTURE; GENERAL ANESTHESIA; HUMAN; LETTER; MALE; MUSCLE WEAKNESS; MYOGRAPHY; NEUROMUSCULAR BLOCKING; OPEN REDUCTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL;

EID: 84863349880     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aes087     Document Type: Letter

References (5)

1. Kitajima O, Suzuki T, Fukano N, Saeki S, Ogawa S, Noda Y. Onset of rocuronium-induced neuromuscular block evaluated subjectively and accerelomyographically at the masseter muscle. J Anesth 2011; 25: 376-9
2. Dalakas MC, Hohlfeld R. Polymyositis and dermatomyositis. Lancet 2003; 362: 971-82
3. Suy K, Morias K, Cammu G, et al. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology 2007; 106: 283-8
4. Suzuki T, Kitajima O, Ueda K, Kondo Y, Kato J, Ogawa S. Reversibility of rocuronium-induced profound neuromuscular block with sugammadex in younger and older patients. Br J Anaesth 2011; 106: 823-6
5. Yoshida F, Suzuki T, Kashiwai A, Furuya T, Konishi J, Ogawa S. Correlation between cardiac output and reversibility of rocuroniuminduced moderate neuromuscular block with sugammadex. Acta Anaesthesiol Scand 2012; 56: 83-7